Cytokinetics Opens Free Registration for May 29 CLIMB Symposium with Phase 3 Updates
Cytokinetics will host its third annual CLIMB symposium on May 29 at San Francisco’s Mission Bay Conference Center; free registration is open until May 22 with limited capacity. The forum covers cardiac and skeletal muscle biology, including positive Phase 3 ACACIA-HCM topline results and planned FDA data discussions.
1. Symposium Overview
Cytokinetics will convene its third annual CLIMB research symposium on May 29, 2026, at the Mission Bay Conference Center in San Francisco. Registration is complimentary but limited and must be completed online by May 22 to secure attendance.
2. Scientific Sessions
The one-day event will feature expert presentations and poster sessions covering cardiac biology topics such as inflammation, energy metabolism and gene therapies, as well as advances in skeletal muscle stem cell regeneration, in vivo gene editing and genetic modifiers of myopathies.
3. Pipeline and Data Highlights
Sessions will also highlight emerging treatment modalities including genetic and RNA medicines, weight-loss approaches, and updates on Cytokinetics’ pipeline with positive Phase 3 ACACIA-HCM topline results slated for full data presentation and FDA submission discussions.